论文部分内容阅读
药品召回制度是国际上盛行的一种药品市场管理制度,但是,在我国,相关制度安排却还有很多的不足之处,一般性的法律规范到现在还没出台。由于权利安排不明晰,消费者没有拒绝缺陷药品的权利,福利遭受损失。同时,厂商也面临承担巨大成本的风险,社会效率受损。通过改变制度安排,实施缺陷药品召回,以此来鼓励和约束厂商行为,在保障消费者福利最大化的同时降低企业成本,以实现社会资源的最优配置。
Drug recall system is an internationally prevailing drug market management system, but in our country, there are still many deficiencies in the relevant institutional arrangements. The general laws and regulations have not been promulgated yet. Welfare was suffered as a result of ambiguous rights arrangements, consumers’ non-refusal of defective medicines. At the same time, manufacturers also face the risk of incurring huge costs and the social efficiency is impaired. By changing institutional arrangements and implementing defective drug recalls, we encourage and constrain manufacturers’ behaviors and maximize the welfare of consumers while reducing the cost of enterprises so as to achieve the optimal allocation of social resources.